Oxaliplatin/5-FU without Leucovorin Chemotherapy in Metastatic Colorectal Cancer
Byoung Yong Shim, Kang Moon Lee, Hyeon-Min Cho, Hyun Jin Kim, Hong Joo Cho, Jinmo Yang, Jun-Gi Kim, Hoon-Kyo Kim
Cancer Res Treat. 2005;37(4):212-215. Published online 2005 Aug 31 DOI: https://doi.org/10.4143/crt.2005.37.4.212
Citations to this article as recorded by 
Clinicopathological Features and Oncological Outcomes of Early and Late Recurrence in Stage III Colorectal Cancer Patients after Adjuvant Oxaliplatin-Based Therapy
Yu-Tang Chang, Hsiang-Lin Tsai, Yen-Cheng Chen, Ching-Chun Li, Ching-Wen Huang, Po-Jung Chen, Wei-Chih Su, Tsung-Kun Chang, Yung-Sung Yeh, Tzu-Chieh Yin, Jaw-Yuan Wang, Weiren Luo
Journal of Oncology.2023; 2023: 1. CrossRef
Targeting the SPHK1/HIF1 Pathway to Inhibit Colorectal Cancer Stem Cells Niche
Saeideh Gholamzadeh Khoei, Hamid Sadeghi, Fateme Karimi Dermani
Journal of Gastrointestinal Cancer.2020; 51(2): 716. CrossRef
Efficacy of 5-FU or Oxaliplatin Monotherapy over Combination Therapy in Colorectal Cancer
Maria Toloudi, Panagiotis Apostolou, Ioannis Papasotiriou
Journal of Cancer Therapy.2015; 06(04): 345. CrossRef
Gene Expression Changes in Colorectal Cancer during Metronomic Chemotherapy and High-Concentration Drug Administration
Panagiotis Apostolou, Maria Toloudi, Irene Kalliara, Vasiliki Kipourou, Ioanna Tourna, Ioannis Papasotiriou
Journal of Cancer Therapy.2015; 06(08): 679. CrossRef